|Articles|April 30, 2021
Analysis of Bevacizumab by SEC–MALLS
Author(s)YMC Europe GmbH
In this application note, YMC’s dedicated SEC column for antibodies, YMC-SEC MAB, has been used to develop a method for bevacizumab using MALLS detection.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Waters Completes Combination with BD Biosciences and Diagnostic Solutions Businesses
2
Volatile Organic Compound Profiling of Commercial Kombucha Using GC-TOF-MS and GC×GC-TOF-MS
3
Chromatography-Based Metabolomic Insights for Safer Kimchi Fermentation
4
A Question of Balance? Part III: Weighing Isn’t an Uncertain Process, Is It?
5